Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Alitretinoin

Research Leaders

5 sponsors active, led by Basilea Pharmaceutica

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Phase 2 (1)
Phase 3 (4)

Trial Status

Completed7

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Alitretinoin3
  • Coconut Oil1
  • Triamcinolone Acetonide Tac Durapeel1

Active Sponsors

  • Basilea Pharmaceutica3
  • Cosmetique Active International1
  • ZARS Pharma Inc.1
  • Fakultas Kedokteran Universitas Indonesia1
  • University Hospital, Brest1

Top Investigators

Related Conditions

  • Hand Eczema1

Activity Timeline